Drug-drug interaction between TAS-303 and simvastatin/midazolam in healthy subjects

Yuji Kumagai,Tomoe Fujita, Masako Aso,Hideki Amano,Yoshinobu Sasaki, Masaki Kawai,Toru Takenaka,Makoto Nagaoka, Koichiro Hoashi

Proceedings for Annual Meeting of The Japanese Pharmacological Society（2018）

引用 0|浏览0

暂无评分

摘要

Background: TAS-303, a selective noradrenaline reuptake inhibitor, is currently at the stage of Phase II development for stress urinary incontinence in Japan.

查看译文

关键词

simvastatin/midazolam,simvastatin/midazolam,drug-drug

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要